Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Welland

Showing results (151-160 of 163) with videos related to

Pageof 17
Sort By:
BJU International|October 19, 2016
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancerDuncan C Gilbert, Trinh Duong, Howard G Kynaston, et al.
Contemporary Clinical Trials Communications|April 16, 2025
Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeuticsLaurence S J Roope, Jessica Walsh, Maddie Welland, et al.
Liver Cancer|August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter StudySabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Cancers|March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter StudyChristian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Hepatology Communications|November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohortTiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Scalable automated reanalysis of genomic data in research and clinical rare disease cohortsMatthew J Welland, K D Ahlquist, Paul De Fazio, et al.
Nature Medicine|June 24, 2026
Automated reanalysis of genomic data for rare disease diagnostics at scaleMatthew J Welland, K D Ahlquist, Paul De Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2024
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical PracticeIvone U S Leong, Claudia P Cabrera, Valentina Cipriani, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Polymorphic tandem repeats influence cell type-specific gene expression across the human immune landscapeHope A Tanudisastro, Anna S E Cuomo, Ben Weisburd, et al.
Pageof 17

Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
BJU International|October 19, 2016
Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancerDuncan C Gilbert, Trinh Duong, Howard G Kynaston, et al.
Contemporary Clinical Trials Communications|April 16, 2025
Reducing inequalities through greater diversity in clinical trials - As important for medical devices as for drugs and therapeuticsLaurence S J Roope, Jessica Walsh, Maddie Welland, et al.
Liver Cancer|August 11, 2022
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter StudySabrina Welland, Catherine Leyh, Fabian Finkelmeier, et al.
Cancers|March 28, 2025
Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter StudyChristian Möhring, Moritz Berger, Farsaneh Sadeghlar, et al.
Hepatology Communications|November 4, 2024
Atezolizumab/bevacizumab and lenvatinib for hepatocellular carcinoma: A comparative analysis in a European real-world cohortTiago de Castro, Sabrina Welland, Leonie Jochheim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2025
Scalable automated reanalysis of genomic data in research and clinical rare disease cohortsMatthew J Welland, K D Ahlquist, Paul De Fazio, et al.
Nature Medicine|June 24, 2026
Automated reanalysis of genomic data for rare disease diagnostics at scaleMatthew J Welland, K D Ahlquist, Paul De Fazio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2024
Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical PracticeIvone U S Leong, Claudia P Cabrera, Valentina Cipriani, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational studySabrina Welland, Ann-Kristin Zöller, Ilektra A Mavroeidi, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Polymorphic tandem repeats influence cell type-specific gene expression across the human immune landscapeHope A Tanudisastro, Anna S E Cuomo, Ben Weisburd, et al.
Pageof 17